Showing results (1691-1700 of 1,907) with videos related to

Sort By:
Pageof 191
Molecular Metabolism|April 27, 2019
An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancerJoseph Longo, Peter J Mullen, Rosemary Yu, et al.
Prostate Cancer and Prostatic Diseases|March 24, 2020
A pilot window-of-opportunity study of preoperative fluvastatin in localized prostate cancerJoseph Longo, Robert J Hamilton, Mehdi Masoomian, et al.
Breast Cancer Research : BCR|September 7, 2019
Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungsMomir Bosiljcic, Rachel A Cederberg, Melisa J Hamilton, et al.
European Urology|February 27, 2014
Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohortBimal Bhindi, Jennifer Locke, Shabbir M H Alibhai, et al.
JAMA|November 22, 2007
Obesity-related plasma hemodilution and PSA concentration among men with prostate cancerLionel L Bañez, Robert J Hamilton, Alan W Partin, et al.
Radiology|February 2, 2021
MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II TrialSangeet Ghai, Antonio Finelli, Kateri Corr, et al.
Journal of Medical Genetics|November 29, 2013
The HNF4A R76W mutation causes atypical dominant Fanconi syndrome in addition to a β cell phenotypeAlexander J Hamilton, Coralie Bingham, Timothy J McDonald, et al.
Malaria Journal|December 10, 2013
Changes in drug sensitivity and anti-malarial drug resistance mutations over time among Plasmodium falciparum parasites in SenegalDaria Van Tyne, Baba Dieye, Clarissa Valim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Large retroperitoneal lymphadenopathy as a predictor of venous thromboembolism in patients with disseminated germ cell tumors treated with chemotherapyAmirrtha Srikanthan, Ben Tran, Michel Beausoleil, et al.
Genes & Development|October 18, 2023
MYC acetylated lysine residues drive oncogenic cell transformation and regulate select genetic programs for cell adhesion-independent growth and survivalMatthew Hurd, Jeffrey Pino, Kay Jang, et al.
Pageof 191